[go: up one dir, main page]

FR2059541B1 - - Google Patents

Info

Publication number
FR2059541B1
FR2059541B1 FR7026720A FR7026720A FR2059541B1 FR 2059541 B1 FR2059541 B1 FR 2059541B1 FR 7026720 A FR7026720 A FR 7026720A FR 7026720 A FR7026720 A FR 7026720A FR 2059541 B1 FR2059541 B1 FR 2059541B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7026720A
Other versions
FR2059541A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orica Ltd
Original Assignee
ICI Australia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICI Australia Ltd filed Critical ICI Australia Ltd
Publication of FR2059541A1 publication Critical patent/FR2059541A1/fr
Application granted granted Critical
Publication of FR2059541B1 publication Critical patent/FR2059541B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7026720A 1969-07-21 1970-07-20 Expired FR2059541B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU5831169 1969-07-21

Publications (2)

Publication Number Publication Date
FR2059541A1 FR2059541A1 (fr) 1971-06-04
FR2059541B1 true FR2059541B1 (fr) 1974-10-11

Family

ID=3743604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7026720A Expired FR2059541B1 (fr) 1969-07-21 1970-07-20

Country Status (9)

Country Link
US (1) US3670086A (fr)
BE (1) BE753710A (fr)
CA (1) CA964193A (fr)
DE (1) DE2036114C3 (fr)
FR (1) FR2059541B1 (fr)
GB (1) GB1287673A (fr)
IE (1) IE34373B1 (fr)
NL (1) NL165653C (fr)
ZA (1) ZA704419B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096271A (en) * 1977-08-03 1978-06-20 American Cyanamid Company Slow release injectable formulations of tetramisole and derivatives in benzyl benzoate
US7648997B2 (en) 2003-08-12 2010-01-19 Coley Pharmaceutical Group, Inc. Hydroxylamine substituted imidazoquinolines
EP1658076B1 (fr) 2003-08-27 2013-03-06 3M Innovative Properties Company Imidazoquinolines substituees par aryloxy et arylalkyleneoxy
EP1660026A4 (fr) 2003-09-05 2008-07-16 3M Innovative Properties Co Traitement pour le lymphome a cellules b cd5+
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
NZ546273A (en) 2003-10-03 2009-05-31 Coley Pharm Group Inc Alkoxy substituted imidazoquinolines
CA2545825A1 (fr) 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitue par hydroxylamine
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
EP1701955A1 (fr) 2003-12-29 2006-09-20 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
WO2005066169A2 (fr) 2003-12-30 2005-07-21 3M Innovative Properties Company Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle
EP1730143A2 (fr) 2004-03-24 2006-12-13 3M Innovative Properties Company Imidazopyridines, imidazoquinolines, et imidazonaphthyridines a substitution amide
WO2005123080A2 (fr) 2004-06-15 2005-12-29 3M Innovative Properties Company Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (fr) * 2004-06-18 2006-01-26 3M Innovative Properties Company Systemes cycliques imidazo substitues, et procedes correspondants
WO2006009826A1 (fr) 2004-06-18 2006-01-26 3M Innovative Properties Company Thiazoloquinolines et thiazolonaphtyridines substitues par aryloxy et arylalkyleneoxy
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
CN101443005A (zh) * 2004-12-30 2009-05-27 科勒制药集团公司 免疫反应调节制剂和方法
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2592904C (fr) 2004-12-30 2015-04-07 3M Innovative Properties Company Composes chiraux a cycle [1,2]imidazo[4,5] fusionne
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
CA2597587A1 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
WO2006107851A1 (fr) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Composes cycliques 1-pyrazolo[3,4-c] substitues comme modulateurs de la biosynthese de cytokine destines au traitement d'infections virales et de maladies neoplastiques
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
CN104906036A (zh) * 2015-06-12 2015-09-16 重庆市畜牧科学院 阿魏酸左旋咪唑注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131034C (fr) * 1964-05-11
AU421744B2 (en) * 1967-08-24 1972-02-24 I. C. I. Australia Limited Chemical process

Also Published As

Publication number Publication date
NL165653B (nl) 1980-12-15
IE34373L (en) 1971-01-21
ZA704419B (en) 1971-04-28
DE2036114B2 (de) 1979-01-18
DE2036114A1 (de) 1971-02-04
IE34373B1 (en) 1975-04-16
NL7010558A (fr) 1971-01-25
BE753710A (fr) 1970-12-31
GB1287673A (en) 1972-09-06
US3670086A (en) 1972-06-13
FR2059541A1 (fr) 1971-06-04
NL165653C (nl) 1981-05-15
CA964193A (en) 1975-03-11
DE2036114C3 (de) 1979-09-13

Similar Documents

Publication Publication Date Title
FR2059541B1 (fr)
AU465413B2 (fr)
AU5461069A (fr)
AU5712069A (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442463B2 (fr)
AU438128B2 (fr)
AU442535B2 (fr)
AU470661B1 (fr)
AT308690B (fr)
AU442538B2 (fr)
AU442380B2 (fr)
AU442285B2 (fr)
AU442322B2 (fr)
AU442554B2 (fr)
AU5228269A (fr)
AU5109569A (fr)
AU5077469A (fr)
CS152743B1 (fr)
AU4540468A (fr)
AU1036070A (fr)
AU5598769A (fr)
AU4949169A (fr)
AU448562A (fr)

Legal Events

Date Code Title Description
CD Change of name or company name